Proposed increase in EPF wage ceiling from Rs 15,000 to Rs 25,000 – What does it mean for employees?

For millions of salaried employees and the organisations that employ them, the proposed increase represents a shift towards social security. (AI image) India’s social security framework is at an important inflection point. After the labour codes, the government is reportedly considering another major reform: raising the wage ceiling for mandatory Employees’ Provident Fund (EPF) coverage…

Read More

Stock market today (April 30, 2026): Sensex drops 583 points, Nifty slips below 24,000; check top gainers and losers list?

Benchmark equity indices Sensex and Nifty closed nearly 1 per cent lower on Thursday as elevated crude oil prices, weak global cues and continued foreign fund outflows hurt investor sentiment.The 30-share BSE Sensex fell 582.86 points, or 0.75 per cent, to settle at 76,913.50. During the session, it plunged as much as 1,237.5 points, or…

Read More

Airfares fluctuation case: ‘What prevents you from filing an affidavit?’ SC pulls up Centre, sets May 8 deadline

The Supreme Court on Thursday questioned the Centre for repeatedly failing to file its affidavit in a plea seeking regulatory guidelines to curb “unpredictable fluctuations” in airfares and ancillary charges imposed by private airlines, PTI reported.A bench of Justices Vikram Nath and Sandeep Mehta asked the Union government to file an application along with an…

Read More

India’s FDI inflow may cross $90 billion in FY26, says DPIIT secretary

India’s total foreign direct investment (FDI) inflows are likely to cross $90 billion in 2025-26 after already surpassing $88 billion during April-February, a top government official said on Thursday.DPIIT Secretary Amardeep Singh Bhatia said the government had undertaken a series of policy measures to attract foreign investments into the country, PTI reported.He said that during…

Read More

AbbVie’s patent on immunology therapy rejected

New Delhi: In good news for patients, Indian Patent Office has refused a patent on MNC firm AbbVie’s blockbuster immunology therapy Rinvoq, paving the way for affordable versions to enter the domestic market. In a recent hearing, the Delhi Patent Office held that the claimed invention was “obvious” and lacked inventive step, a violation of…

Read More